Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raymond Miller

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Journal of the American Dental Association (1939)|December 2, 2011
The crash of Colgan Air flight 3407: Advanced techniques in victim identificationMary Bush, Raymond Miller
The European Respiratory Journal|April 17, 2021
Reduction in <i>T</i> <sub>LCO</sub> and survival in a clinical populationMartin Raymond Miller, Brendan G Cooper
Journal of Clinical Pharmacology|October 1, 2010
Models for event-driven data: longitudinal daily adverse event and dropoutRaymond Miller, Kaori Ito, Bojan Lalovic
Clinical Drug Investigation|September 5, 2014
Population pharmacokinetics and dose-exposure proportionality of edoxaban in healthy volunteersOphelia Q P Yin, Raymond Miller
Journal of Pharmacokinetics and Pharmacodynamics|October 24, 2003
Evaluation of mixture modeling with count data using NONMEMBill Frame, Raymond Miller, Richard L Lalonde
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2009
Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorderBill Frame, Raymond Miller, Matthew M Hutmacher
BMJ Case Reports|November 4, 2018
Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcomaAlexander Waselewski, Michael Joiner, Steven Raymond Miller
European Journal of Clinical Pharmacology|August 30, 2014
Edoxaban population pharmacokinetics and exposure-response analysis in patients with non-valvular atrial fibrillationOphelia Q P Yin, Kimura Tetsuya, Raymond Miller
Journal of Clinical Pharmacology|July 29, 2010
Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorderBojan Lalovic, Matt Hutmacher, Bill Frame, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 27, 2008
An alternative method for population pharmacokinetic data analysis under noncompliancePankaj Gupta, Matthew M Hutmacher, Bill Frame, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Journal of the American Dental Association (1939)|December 2, 2011
The crash of Colgan Air flight 3407: Advanced techniques in victim identificationMary Bush, Raymond Miller
The European Respiratory Journal|April 17, 2021
Reduction in <i>T</i> <sub>LCO</sub> and survival in a clinical populationMartin Raymond Miller, Brendan G Cooper
Journal of Clinical Pharmacology|October 1, 2010
Models for event-driven data: longitudinal daily adverse event and dropoutRaymond Miller, Kaori Ito, Bojan Lalovic
Clinical Drug Investigation|September 5, 2014
Population pharmacokinetics and dose-exposure proportionality of edoxaban in healthy volunteersOphelia Q P Yin, Raymond Miller
Journal of Pharmacokinetics and Pharmacodynamics|October 24, 2003
Evaluation of mixture modeling with count data using NONMEMBill Frame, Raymond Miller, Richard L Lalonde
Journal of Pharmacokinetics and Pharmacodynamics|November 12, 2009
Joint modeling of dizziness, drowsiness, and dropout associated with pregabalin and placebo treatment of generalized anxiety disorderBill Frame, Raymond Miller, Matthew M Hutmacher
BMJ Case Reports|November 4, 2018
Acute myeloid leukaemia relapse presenting as cardiac myeloid sarcomaAlexander Waselewski, Michael Joiner, Steven Raymond Miller
European Journal of Clinical Pharmacology|August 30, 2014
Edoxaban population pharmacokinetics and exposure-response analysis in patients with non-valvular atrial fibrillationOphelia Q P Yin, Kimura Tetsuya, Raymond Miller
Journal of Clinical Pharmacology|July 29, 2010
Modeling dropout from adverse event data: impact of dosing regimens across pregabalin trials in the treatment of generalized anxiety disorderBojan Lalovic, Matt Hutmacher, Bill Frame, et al.
Journal of Pharmacokinetics and Pharmacodynamics|February 27, 2008
An alternative method for population pharmacokinetic data analysis under noncompliancePankaj Gupta, Matthew M Hutmacher, Bill Frame, et al.
Pageof 5